Clinical evaluation of EliA tests for MPO-ANCA and PR3-ANCA

Clinical evaluation of EliA tests for MPO-ANCA and PR3-ANCA - Clinical evaluation of EliA tests for MPO-ANCA and PR3-ANCA

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007229

Enrollment

155

Registered

2012-02-06

Start date

2012-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wegener&#39

Interventions

obtain a blood sample

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Clinical infomation was retrieved for all of these patients and patients with a vasculitis were subgrouped according to the nomenclature of the Chapel Hill consensus conference, and for ANCA associated angiitis the criteria.

Exclusion criteria

Exclusion criteria: not available

Design outcomes

Primary

Measure	Time frame
1) clinical sensitivity and specificity of Elia tests in disease controls and healthly controls. 2) Results of Elia tests in disease controls and healthly controls. 3)PR3-ANCA and MPO-ANCA EliA test in the follow-up of patient with Wegener's granulomatosis and Allergic granulomatous angiitis.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026